Profile data is unavailable for this security.
About the company
Sinocelltech Group Ltd is a China-based company mainly engaged in the research, development and industrialization of biopharmaceutical products. The Company focuses on monoclonal antibodies, recombinant proteins and vaccine products. Its main products are SCT800, SCT200, SCT-I10A, SCT400, SCT510, SCT1000 and SCT630, among others. The Company is also engaged in asset leasing business and payment collection business.
- Revenue in CNY (TTM)2.17bn
- Net income in CNY-168.81m
- Incorporated2007
- Employees2.33k
- LocationSinocelltech Group LtdBlock 5, No. 31 Kechuang Qi StreetBeijing Economic and Technological DevelBEIJING 100176ChinaCHN
- Phone+86 1 058628328
- Fax+86 1 058628299
- Websitehttps://www.sinobiological.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bio-Thera Solutions Ltd | 711.46m | -370.90m | 8.26bn | 1.17k | -- | 7.55 | -- | 11.61 | -0.8957 | -0.8957 | 1.72 | 2.64 | 0.3099 | 0.9439 | 6.06 | 609,647.70 | -16.15 | -23.62 | -23.70 | -30.81 | 71.41 | 79.76 | -52.13 | -106.72 | 0.8258 | -367.55 | 0.3515 | -- | 54.86 | -- | 17.87 | -- | -3.78 | -- |
| Joinn Laboratories China Co Ltd | 2.33bn | -62.99m | 9.56bn | 2.50k | -- | 1.30 | -- | 4.10 | -0.0862 | -0.0862 | 3.12 | 10.75 | 0.23 | 0.6906 | 8.14 | -- | -0.6856 | 8.99 | -0.8219 | 11.07 | 39.46 | 46.76 | -2.98 | 32.01 | 3.51 | 0.9996 | 0.0079 | 23.81 | 4.78 | 42.20 | -63.04 | 29.66 | 8.21 | 23.46 |
| Mabwell Shanghai Bioscience Co Ltd | 191.35m | -1.02bn | 9.63bn | 1.49k | -- | 4.00 | -- | 50.33 | -2.55 | -2.55 | 0.4789 | 6.02 | 0.0412 | 0.0472 | 16.79 | 128,337.60 | -22.02 | -37.61 | -26.37 | -45.95 | 96.84 | 81.54 | -534.78 | -2,112.26 | 1.96 | -- | 0.442 | -- | 361.03 | 27.88 | -10.28 | -- | 17.35 | -- |
| Dizal Jiangsu Pharmaceutical Co Ltd | 172.61m | -1.09bn | 15.34bn | 581.00 | -- | 22.02 | -- | 88.86 | -2.67 | -2.67 | 0.422 | 1.68 | 0.1008 | 0.3215 | 6.78 | 297,086.40 | -63.79 | -46.02 | -82.62 | -52.99 | 96.41 | 57.53 | -632.90 | -2,081.54 | 1.74 | -- | 0.4557 | -- | -- | 18.29 | -50.50 | -- | 21.35 | -- |
| Sinocelltech Group Ltd | 2.17bn | -168.81m | 16.46bn | 2.33k | -- | -- | -- | 7.58 | -0.3791 | -0.3791 | 4.88 | -1.16 | 0.761 | 0.3743 | 6.86 | 930,592.90 | -5.93 | -40.17 | -15.48 | -74.63 | 96.35 | 95.42 | -7.79 | -108.20 | 0.4649 | 3.33 | 1.23 | -- | 84.46 | 264.19 | 23.70 | -- | 37.54 | -- |
| Shanghai Allist Pharmaceuticals Co Ltd | 2.48bn | 915.35m | 23.05bn | 1.04k | 25.18 | 5.33 | -- | 9.28 | 2.03 | 2.03 | 5.52 | 9.60 | 0.6091 | 3.16 | 10.51 | 2,379,802.00 | 22.44 | 0.6405 | 24.19 | 0.6933 | 94.48 | 96.42 | 36.84 | 2.54 | 8.22 | -- | 0.0004 | 211.88 | 155.14 | 237.34 | 393.54 | -- | 13.53 | -- |
Data as of Jul 29 2024. Currency figures normalised to Sinocelltech Group Ltd's reporting currency: Chinese Yuan Renminbi CNY
3.09%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| China Merchants Fund Management Co., Ltd.as of 30 Sep 2023 | 1.99m | 0.45% |
| Penghua Fund Management Co., Ltd.as of 31 Dec 2023 | 1.82m | 0.41% |
| Bosera Asset Management Co., Ltd.as of 31 Dec 2023 | 1.70m | 0.38% |
| China Foreign Economy & Trade Trust Co., Ltd.as of 30 Sep 2023 | 1.48m | 0.34% |
| Perseverance Asset Management LPas of 30 Sep 2023 | 1.47m | 0.33% |
| Yinhua Fund Management Co., Ltd.as of 31 Dec 2023 | 1.31m | 0.30% |
| China Southern Asset Management Co., Ltd.as of 31 Dec 2023 | 1.28m | 0.29% |
| GF Fund Management Co., Ltd.as of 31 Dec 2023 | 976.63k | 0.22% |
| The Vanguard Group, Inc.as of 04 Jul 2024 | 877.43k | 0.20% |
| Tian Hong Asset Management Co., Ltd.as of 31 Dec 2023 | 774.12k | 0.18% |
More ▼
Data from 31 Dec 2023 - 24 Jul 2024Source: FactSet Research Systems Inc.
